Novo Nordisk Aktie
WKN DE: A3EU6F / ISIN: DK0062498333
25.09.2025 13:30:00
|
3 Reasons to Buy Novo Nordisk Stock Right Now
The bigger they are, the harder they fall. That saying applies to Novo Nordisk (NYSE: NVO) and its poor performance over the past year.The company was one of the largest healthcare stocks, and a leader in the emerging and fast-growing market for weight management medicines, coming into 2024. However, due to a series of setbacks, the stock has lost more than 40% of its value over the trailing-12-month period.Despite Novo Nordisk's issues, though, there remain excellent reasons to invest in the stock. Below are just three of them.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Novo Nordisk (spons. ADRs)mehr Nachrichten
Analysen zu Novo Nordiskmehr Analysen
22.09.25 | Novo Nordisk Neutral | UBS AG | |
19.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
18.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
18.09.25 | Novo Nordisk Neutral | UBS AG | |
18.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. |
Aktien in diesem Artikel
Novo Nordisk | 46,83 | -2,24% |
|
Novo Nordisk (spons. ADRs) | 47,70 | -1,04% |
|
NOW Inc When Issued | 13,10 | 0,00% |
|